Document Detail


Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
MedLine Citation:
PMID:  15314994     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the study was to evaluate the usefulness of TRAb determinations in predicting and monitoring the effectiveness of various forms of treatment in Graves-Basedow's disease. 144 patients with Graves-Basedow's disease aged 18-76 years, x-44 were studied. Group I--54 patients treated with methizole, group II--45 patients treated with 131 I, group III--45 patients subjected to operative procedures. The TSH receptor antibodies were determined using the radioimmunoassay (TRAK-assay, Henning). The examinations were performed before, 12 and 18 months after treatment. Irrespective of the treatment type, the highest initial TRAb values were observed in the groups of patients with ineffective treatment (thiamazole x- 54.39+/-31.23 U/l, radioiodine x- 103.61+/-43.90 U/l, operative procedures x- 104.00+/- 52.34 U/l). During the 12-month follow-up of the patients subjected to surgery and 18-month follow-up of those undergoing conservative treatment, the level of antibodies did not normalize (x- 40.17+/-33.06, x- 77.18+/-44.92, x- 58.77+/-54.67, respectively). In the groups with effective treatment, the TRAb levels normalized. 1. The level of TSH receptor antibodies is a good marker for monitoring the effectiveness of treatment in Graves-Basedow's disease. 2. The high initial antibody level, irrespective of the kind of treatment instituted, is a bad prognostic feature. 3. The TRAb determinations performed 12 months after the institution of treatment also show some prognostic value. 4. The lack of normalization of antibody levels during treatment is associated with persistent hyperthyroidism, irrespective of the form of therapy.
Authors:
Anna Bojarska-Szmygin; Krzysztof Janicki; Radosław Pietura; Lucyna Janicka
Related Documents :
17949264 - Susceptible alleles of the cd40 and ctla-4 genes are not associated with the relapse af...
9823404 - Early relapse after operation for graves' disease: postoperative hormone kinetics and o...
18592264 - Is central neck dissection a safe procedure in the treatment of papillary thyroid cance...
19602794 - Thyrotoxicosis complicated with dysphagia.
9408414 - A randomized comparison between minilaparotomy and conventional approach for aortoiliac...
22853784 - Onabotulinum toxin a for the treatment of neurogenic detrusor overactivity due to spina...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Annales Universitatis Mariae Curie-Skłodowska. Sectio D: Medicina     Volume:  58     ISSN:  0066-2240     ISO Abbreviation:  Ann Univ Mariae Curie Sklodowska Med     Publication Date:  2003  
Date Detail:
Created Date:  2004-08-18     Completed Date:  2004-11-09     Revised Date:  2009-06-05    
Medline Journal Info:
Nlm Unique ID:  0414101     Medline TA:  Ann Univ Mariae Curie Sklodowska Med     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  248-53     Citation Subset:  IM    
Affiliation:
Laboratory of Nuclear Medicine, Cardinal Stefan Wyszyński Specialist Hospital, Lublin, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antithyroid Agents / therapeutic use*
Autoantibodies / blood*
Biological Markers / blood
Female
Follow-Up Studies
Graves Disease / drug therapy,  immunology*,  radiotherapy,  therapy*
Humans
Immunoglobulins, Thyroid-Stimulating
Iodine Radioisotopes / therapeutic use*
Male
Methimazole / therapeutic use*
Middle Aged
Predictive Value of Tests
Receptors, Thyrotropin / blood*
Sensitivity and Specificity
Thyroidectomy
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antithyroid Agents; 0/Autoantibodies; 0/Biological Markers; 0/Immunoglobulins, Thyroid-Stimulating; 0/Iodine Radioisotopes; 0/Receptors, Thyrotropin; 0/thyrotropin-binding inhibitory immunoglobulin; 60-56-0/Methimazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The usefulness of thyroid size and TSH receptor antibody (TRAb) determinations in predicting the eff...
Next Document:  The professional burnout syndrome in radiologists.